by creavo | Nov 22, 2019 | Press Release
22 November 2019: UK medical device company Creavo Medical Technologies (Creavo) has begun a pioneering 510-patient study with University Hospitals Coventry and Warwickshire (UHCW) NHS Trust, to evaluate the role of magnetocardiography (MCG) in the prediction of...
by creavo | Sep 2, 2019 | News, Press Release
August 2019: UK medical device company Creavo Medical Technologies has appointed its Operations Director Andrew Mullen to its Board of Directors, a role which will see him lead on research and development (R&D) and regulatory affairs. Andrew has held the...
by creavo | Jul 19, 2018 | News, Press Release
A new cardiac diagnostic device aimed at helping physicians rule out active ischaemia in patients presenting to the emergency department (ED) with chest pain is being trialled at five of the most respected research facilities in the United States (Mayo Clinic,...
by creavo | May 21, 2018 | News, Press Release
Trial tests the viability of Creavo’s MCG device at five major emergency departments across the UK. Creavo Medical Technologies (Creavo), the UK-based medical device company, has completed patient enrollment in its multi-centre study. Involving 750 patients across...
by creavo | May 3, 2018 | News, Press Release
Chris Meredith and Pierre Chauvineau bring a wealth of experience to the growing business Creavo Medical Technologies (Creavo), the UK-based medical device company has appointed senior medical technology industry leaders Chris Meredith and Pierre Chauvineau as...
by creavo | Oct 16, 2017 | News, Press Release
Technology has the potential to revolutionise emergency department triage of chest pain patients. Developer of innovative medical diagnostic technology, Creavo Medical Technologies, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). The...
